⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18198948 | 0.73 | ALDH1A1 (0.39) | — | |
| SCHEMBL8056183 | 0.69 | — | — | |
| SCHEMBL15020100 | 0.69 | — | — | |
| SCHEMBL12629751 | 0.68 | — | — | |
| SCHEMBL14467763 | 0.65 | — | — | |
| SCHEMBL10602987 | 0.65 | — | — | |
| SCHEMBL12257159 | 0.64 | — | — | |
| SCHEMBL3292052 | 0.64 | MAPT (0.37) | — | |
| SCHEMBL15020363 | 0.64 | — | — | |
| SCHEMBL11548175 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2791251-A1 | TRI-AROMATIC AZOMETHINE DIRECT DYES COMPRISING AT LEAST ONE UNIT DERIVED FROM RESORCINOL, DYEING COMPOSITION, METHOD AND USE | L'OREAL (FR) | 2014-10-22 | — | — | EP | claimed |
| WO-2013087772-A1 | TRI-AROMATIC AZOMETHINE DIRECT DYES COMPRISING AT LEAST ONE UNIT DERIVED FROM RESORCINOL, DYEING COMPOSITION, METHOD AND USE | L'OREAL (FR) | 2013-06-20 | — | — | WO | claimed |
| US-9921479-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-03-20 | — | — | US | disclosed |
| US-20160320699-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-11-03 | — | — | US | disclosed |
| US-20160320699-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-11-03 | — | — | US | disclosed |
| EP-3088955-A2 | RESIST COMPOSITION AND PATTERNING PROCESS | Shin-Etsu Chemical Co., Ltd. (JP) | 2016-11-02 | — | — | EP | disclosed |
| US-9422388-B2 | PU compositions containing complexed catalysts | HENKEL AG & CO. KGAA (DE) | 2016-08-23 | — | — | US | disclosed |
| US-20160038561-A1 | TREATMENT OF ENDOMETRIOSIS, ANGIOGENESIS AND/OR ENDOMETRIAL LESION GROWTH | SYNG PHARMACEUTICALS, INC. (CA) | 2016-02-11 | — | — | US | disclosed |
| US-20140155445-A1 | Compounds and Methods for Treating Cancer and Diseases of the Central Nervous System | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 2014-06-05 | — | — | US | disclosed |
| US-8703698-B2 | Compositions and methods for treating atherosclerosis | THE UNIVERSITY OF CHICAGO (US) | 2014-04-22 | — | — | US | disclosed |
| US-8629135-B2 | Pharmaceutical compositions comprising RET inhibitors and methods for the treatment of cancer | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 2014-01-14 | — | — | US | disclosed |
| US-20090291902-A1 | INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE | VERTEX PHARMACEUTICALS INCORPORATED | 2009-11-26 | — | — | US | disclosed |
| US-20090221564-A1 | Heterocyclic Compounds and Their Use in the Treatment of Cardiovascular Disease | TRIGEN LIMITED (GB) | 2009-09-03 | — | — | US | disclosed |
| US-20090176831-A1 | Compounds and Methods for Treating Cancer and Diseases of the Central Nervous System | OSTA BIOTECHNOLOGIES (CA) | 2009-07-09 | — | — | US | disclosed |
| US-20080311079-A1 | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2008-12-18 | — | — | US | disclosed |
| US-20080221028-A1 | Compositions and Methods for Treating Atherosclerosis | THE UNIVERSITY OF CHICAGO | 2008-09-11 | — | — | US | disclosed |
| US-7378422-B2 | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2008-05-27 | — | — | US | disclosed |
| US-7291590-B2 | Compositions and methods for treating atherosclerosis | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 2007-11-06 | — | — | US | disclosed |
| US-20070238667-A1 | Compositions for treatment of cancer | JIA, ZONGCHAO (CA) | 2007-10-11 | — | — | US | disclosed |
| US-20070232545-A1 | Compositions and Methods for Treating Atherosclerosis | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 2007-10-04 | — | — | US | disclosed |